ICPO Foundation kooperiert mit Nuclear Medicine Research Infrastructure (NuMeRI), um ein ICPO Collaborating Center zu etablieren
July 04, 2024 00:00 ET
|
ICPO Foundation
Diese Zusammenarbeit verbessert die globalen Bildungsstandards in der Radiotheranostik und zielt darauf ab, den Zugang der Patienten zu einer neuen Ära effektiver Krebstherapien in Südafrika zu...
Save the date: Die neue Ära der Krebsbehandlung wird präsentiert auf dem ICPO Theranostics Virtual Summit, 14. - 15. November 2024
June 27, 2024 00:00 ET
|
ICPO Foundation
Die neue Ära der Krebsbehandlung wird präsentiert auf dem ICPO Theranostics Virtual Summit, 14. - 15. November 2024 Die ICPO Foundation bietet ein erstklassiges wissenschaftliches Programm, das...
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024
June 27, 2024 00:00 ET
|
ICPO Foundation
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024 The ICPO Foundation offers a world-class scientific...
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
May 06, 2024 08:00 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Particle Therapy Market to hit USD 1.7 Bn by 2032, says Global Market Insights Inc.
April 29, 2024 04:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, April 29, 2024 (GLOBE NEWSWIRE) -- Particle Therapy Market Size will reach more than USD 1.7 billion by 2032. The surging global burden of cancer is an important trend...
Oncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMR
April 24, 2024 12:26 ET
|
Dimension Market Research
New York, April 24, 2024 (GLOBE NEWSWIRE) -- Overview According to Dimension Market Research, The Global Oncology Market size was valued USD 234.6 billion in 2023 and it is further anticipated...
Medicovestor Selected as Finalist to Present Its First-in-Class ADC Platforms at JP Morgan Asset Management: Life Sciences Innovation Summit
April 05, 2024 10:00 ET
|
Medicovestor Inc
Medicovestor named finalist for JP Morgan Asset Management: Life Sciences Innovation Summit, showcasing pioneering ADC platforms on May 14th – 15th, 2024.
HNL Lab Medicine Unveils Lifesaving Cellular Therapy Laboratory
April 01, 2024 14:01 ET
|
Health Network Laboratories (HNL Lab Medicine)
HNL Lab Medicine partners with LVHN to open cellular therapy laboratory, first in Lehigh Valley; capable of apheresis collections and stem cell processing
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
March 25, 2024 08:02 ET
|
TeleDaas PLLC
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024
March 19, 2024 08:00 ET
|
Ludwig Enterprises, Inc.
SPARKS, Nev., March 19, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc, (OTC: LUDG): A US-based biotechnology company is pleased to announce it has entered the booming artificial intelligence...